Elucidating the intricate mechanisms of gastrointestinal bleeding in a continuous-flow left ventricular assist device will lead to future therapeutic targets Liza Grosman-Rimon, PhD, Vivek Rao, MD, PhD The Journal of Thoracic and Cardiovascular Surgery Volume 152, Issue 1, (July 2016) DOI: 10.1016/j.jtcvs.2016.03.014 Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions
Figure 1 Future research directions should focus on: (1) Strategies to improve patient assessment and selection for continuous-flow left ventricular assist device (CF-LVAD) therapy and (2) the mechanisms of gastrointestinal (GI) bleeding and the complex interactions among them to evaluate the risk for GI bleeding and explore future therapeutic targets. The Journal of Thoracic and Cardiovascular Surgery 2016 152, DOI: (10.1016/j.jtcvs.2016.03.014) Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions
The Journal of Thoracic and Cardiovascular Surgery 2016 152, DOI: (10 The Journal of Thoracic and Cardiovascular Surgery 2016 152, DOI: (10.1016/j.jtcvs.2016.03.014) Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions